Lower health care utilization was shown in patients with chronic rhinosinusitis, with and without nasal polyps, who had steroid-eluting implants vs those who did not in the 18 months following ...
CMS Approves SINUVA® Sinus Implant for Reimbursement with New C-Code and Pass-Through Payment Status
MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced that the Centers ...
MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...
Medtronic boosts ear, nose and throat portfolio with $1.1B bid for sinus implant maker Intersect ENT
Medtronic’s latest acquisition is nothing to sneeze at, with an offer of more than $1 billion for a handful of devices already cleared in the U.S. and Europe. The medtech giant has set its sights on ...
LONDON--(BUSINESS WIRE)--The global nasal implants market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results